Takahashi, Aya <br/><br/>
Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.  [electronic resource] 

 -  Journal of nephrology  Dec 2014 
 - 627-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1724-6059 
<br/><br/><label>Standard No.: </label>10.1007/s40620-014-0147-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Animals<br/>Biphenyl Compounds--pharmacology<br/>Disease Models, Animal<br/>Disease Progression<br/>Female<br/>Gene Expression Regulation<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Irbesartan<br/>Kidney Glomerulus--drug effects<br/>Membrane Proteins--genetics<br/>Nephrosis, Lipoid--chemically induced<br/>Proteinuria--chemically induced<br/>Puromycin Aminonucleoside<br/>Rats, Wistar<br/>Receptor, Angiotensin, Type 1--drug effects<br/>Tetrazoles--pharmacology<br/>Time Factors